BDBM761446 2-(2,6-dioxopiperidin-3-yl)- 5-fluoro-6-(piperazin-1-yl- 2,2,3,3,5,5,6,6-d8)isoindoline- 1,3-dione::US20250243210, Compound GT-03108

SMILES [2H]C1([2H])NC([2H])([2H])C([2H])([2H])N(c2cc3c(cc2F)C(=O)N(C2CCC(=O)NC2=O)C3=O)C1([2H])[2H]

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 761446   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM761446(2-(2,6-dioxopiperidin-3-yl)- 5-fluoro-6-(piperazin...)
Affinity DataIC50: 8.75E+3nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/12/2025
Entry Details
US Patent